Search

Your search keyword '"Aphthovirus metabolism"' showing total 111 results

Search Constraints

Start Over You searched for: Descriptor "Aphthovirus metabolism" Remove constraint Descriptor: "Aphthovirus metabolism"
111 results on '"Aphthovirus metabolism"'

Search Results

1. Aggregation-associated loss of antigenicity observed for denatured virion protein 1 of Equine rhinitis A virus in an enzyme-linked immunosorbent assay.

2. Root cause investigation of a viral contamination incident occurred during master cell bank (MCB) testing and characterization--a case study.

3. Evidence for an RNA chaperone function of polypyrimidine tract-binding protein in picornavirus translation.

4. Subcellular distribution of the foot-and-mouth disease virus 3A protein in cells infected with viruses encoding wild-type and bovine-attenuated forms of 3A.

5. Foot-and-mouth disease virus can utilize the C-terminal extension of coxsackievirus A9 VP1 for cell infection.

6. The 'cleavage' activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring '2A-like' sequences.

7. Analysis of the aphthovirus 2A/2B polyprotein 'cleavage' mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal 'skip'.

8. Role of the cytoplasmic domain of the beta-subunit of integrin alpha(v)beta6 in infection by foot-and-mouth disease virus.

9. Type-independent detection of foot-and-mouth disease virus by monoclonal antibodies that bind to amino-terminal residues of capsid protein VP2.

10. High-efficiency utilization of the bovine integrin alpha(v)beta(3) as a receptor for foot-and-mouth disease virus is dependent on the bovine beta(3) subunit.

11. The epithelial integrin alphavbeta6 is a receptor for foot-and-mouth disease virus.

12. Foot-and-mouth disease virus is a ligand for the high-affinity binding conformation of integrin alpha5beta1: influence of the leucine residue within the RGDL motif on selectivity of integrin binding.

13. Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage.

14. C-terminal region of VP1 of selected foot-and-mouth disease virus serotypes: expression in E. coli and affinity purification.

15. Interaction of eukaryotic initiation factor eIF4B with the internal ribosome entry site of foot-and-mouth disease virus is independent of the polypyrimidine tract-binding protein.

16. The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex.

17. An RNA virus can adapt to the multiplicity of infection.

18. Conformational flexibility in a highly mobile protein loop of foot-and-mouth disease virus: distinct structural requirements for integrin and antibody binding.

19. Parameters influencing translational efficiency in aphthovirus IRES-based bicistronic expression vectors.

20. Multiple virulence determinants of foot-and-mouth disease virus in cell culture.

21. [Physico-chemical bases of the mechanism of thermal inactivation of the foot-and-mouth disease virus].

22. Specific interactions between human integrin alpha v beta 3 and chimeric hepatitis B virus core particles bearing the receptor-binding epitope of foot-and-mouth disease virus.

23. Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus.

24. Arginine-glycine-aspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin alpha(v)beta3 in vitro.

25. Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle.

26. Characterization of synthetic foot-and-mouth disease virus provirions separates acid-mediated disassembly from infectivity.

27. The cleavage activities of aphthovirus and cardiovirus 2A proteins.

28. A recombinant, arginine-glycine-aspartic acid (RGD) motif from foot-and-mouth disease virus binds mammalian cells through vitronectin and, to a lower extent, fibronectin receptors.

29. Mengovirus leader is involved in the inhibition of host cell protein synthesis.

30. Stability of foot-and-mouth disease virus, its genome and proteins at 37 degrees C.

31. Intracellular membrane proliferation in E. coli induced by foot-and-mouth disease virus 3A gene products.

32. Antigenic analysis of SAT 2 serotype foot-and-mouth disease virus isolates from Zimbabwe using monoclonal antibodies.

33. Interaction of eukaryotic initiation factor eIF-4B with a picornavirus internal translation initiation site.

34. Viral RNA modulates the acid sensitivity of foot-and-mouth disease virus capsids.

35. Animal-derived antigenic variants of foot-and-mouth disease virus type A12 have low affinity for cells in culture.

36. Unprocessed foot-and-mouth disease virus capsid precursor displays discontinuous epitopes involved in viral neutralization.

37. Foot-and-mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein.

38. Expression of an animal virus antigenic site on the surface of a plant virus particle.

39. Transient inhibition of foot-and-mouth disease virus infection of BHK-21 cells by antisense oligonucleotides directed against the second functional initiator AUG.

40. VPg gene amplification correlates with infective particle formation in foot-and-mouth disease virus.

41. Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence.

42. Myristoylation of foot-and-mouth disease virus capsid protein precursors is independent of other viral proteins and occurs in both mammalian and insect cells.

43. [Synthesis of a 17-member peptide (143-159)--the VP(1) protein fragment of A(12) foot-and-mouth disease virus. II. Condensation of fragments].

45. A cellular 57 kDa protein binds to two regions of the internal translation initiation site of foot-and-mouth disease virus.

46. The effect of peptides containing the arginine-glycine-aspartic acid sequence on the adsorption of foot-and-mouth disease virus to tissue culture cells.

47. [Electron microscopy studies on the proliferation of foot-and-mouth disease virus in cell cultures. III. Morphogenesis in cytoplasm].

48. Foot-and-mouth disease virus RNA. Presence of 3'-terminal polyriboadenylic acid and absence of amino acid binding ability.

49. Localization of foot-and-mouth disease--RNA synthesis on newly formed cellular smooth membranous vacuoles.

Catalog

Books, media, physical & digital resources